Advances in immunomodulatory microneedles for diabetic wound healing

microneedles, including small molecules, proteins, nucleic acids, cells, exosomes, inorganic agents, gaseous therapeutics, and integrated multifunctional platforms. Finally, we outline the current challenges in optimizing microneedle-based immunotherapies and discuss future directions toward clinical translation.